The Board of Directors of the Company at their meeting held on 31-03-2025 (1) rescinded its decision to appoint Mr. Manoj Lodha as Executive Director & Chief Financial Officer upon his withdrawal of consent and (2) Mr. Sachin Mehta to continue as Joint Managing Director & Chief Financial Officer of the Company. (Details given in the files attached).
Announcement under Regulation 30 (LODR)-Change in Directorate
Filed with BSE · · 6 pages · English
Release
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Mar 26 2025
- Change In Market Maker Of The Company
- Sudarshan Pharma Industries Ltd Press Release Mar 20 2025
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Sudarshan Pharma Industries Ltd Press Release Mar 06 2025
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Sudarshan Pharma Industries Ltd Press Release Apr 03 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Board Meeting Intimation for Approval Of Financial Results On Thursday, 24-04-2025
- Sudarshan Pharma Industries Ltd Press Release Apr 21 2025
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries